Turn Biotechnologies to Present at the Guggenheim Healthcare

/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced...

Related Keywords

Jim Martinez , Anja Krammer , , Turn Biotechnologies , Chief Executive Officer , Guggenheim Healthcare Talks , Genomic Medicines , Rare Disease Days , Epigenetic Reprogramming , Delivery Platform ,